ArticlePLoS neglected tropical diseases2026
Prevalence of HTLV-1 and HTLV-2 infection among transgender women in Brazil: A multicenter study.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTransgender Women and Travestis (TWT) are at increased risk for sexually transmitted infections due to contexts of vulnerability related to socioeconomic and behavioral factors. However, data on the prevalence of Human T-lymphotropic viruses type 1 and 2 (HTLV-1/2) in this population remain scarce. This study aimed to investigate the seroprevalence of HTLV-1/2 infection among TWT in five Brazilian capitals. METHODOLOGY/PRINCIPAL
findingsA cross-sectional study was conducted from 2019 to 2021 in five Brazilian capital cities, representing all geographic regions of the country. A total of 1,269 blood samples were tested for HTLV-1/2 antibodies using ELISA and Western Blot assays. Sociodemographic and behavioral data were obtained through structured interviews. Among 1,269 samples, most participants identifying as transgender women (59.18%) or travestis (29.79%) with a median age of 30 years. A total of 12 samples tested positive for anti-HTLV-1/2 (0.94%; CI 95%: 0.53-1.65), with positive cases in Manaus (n = 4, 1.50%), Salvador (n = 4, 2.22%), and Porto Alegre (n = 4, 2.12%), and none in São Paulo or Campo Grande. Associated behaviors included inconsistent condom use and a history of HIV and syphilis. CONCLUSIONS/SIGNIFICANCE: Our study highlights the presence of HTLV-1/2 infection among TWT in Brazil, with regional differences. These findings underscore the need for targeted public health interventions, including increased screening, health education, and access to healthcare services, to address the specific vulnerabilities of this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.